As on Wednesday, Heart Test Laboratories Inc. (NASDAQ: HSCS) got off with the flyer as it spiked 9.10% to $0.11, before settling in for the price of $0.10 at the close. Taking a more long-term approach, HSCS posted a 52-week range of $0.09-$1.32.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -56.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 75.00%. This publicly-traded company’s shares outstanding now amounts to $65.56 million, simultaneously with a float of $54.96 million. The organization now has a market capitalization sitting at $7.07 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1172, while the 200-day Moving Average is $0.3486.
Heart Test Laboratories Inc. (HSCS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Heart Test Laboratories Inc.’s current insider ownership accounts for 16.16%, in contrast to 1.84% institutional ownership.
Heart Test Laboratories Inc. (HSCS) Earnings and Revenue Records
Heart Test Laboratories Inc.’s EPS increase for this current 12-month fiscal period is 75.00% and is forecasted to reach -0.10 in the upcoming year.
Heart Test Laboratories Inc. (NASDAQ: HSCS) Trading Performance Indicators
Let’s observe the current performance indicators for Heart Test Laboratories Inc. (HSCS). It’s Quick Ratio in the last reported quarter now stands at 4.32. The Stock has managed to achieve an average true range (ATR) of 0.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 353.70.
In the same vein, HSCS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.48, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.10 at the market close of one year from today.
Technical Analysis of Heart Test Laboratories Inc. (HSCS)
Through scrutinizing the latest numbers posted by the [Heart Test Laboratories Inc., HSCS], it can be observed that its last 5-days Average volume of 6.6 million was better the volume of 2.79 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 39.19% While, its Average True Range was 0.0103.
Raw Stochastic average of Heart Test Laboratories Inc. (HSCS) in the period of the previous 100 days is set at 10.85%, which indicates a major fall in contrast to 46.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 69.07% that was lower than 107.64% volatility it exhibited in the past 100-days period.
